Loading Events

« All Events

  • This event has passed.

NIH R01 Cycles

February 5

|Recurring Event (See all)

One event on June 5, 2020 at 12:00 am

One event on October 5, 2020 at 12:00 am

Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R01 Clinical Trial Optional):
The purpose of this funding opportunity announcement (FOA) is to stimulate clinical research focused on biobehavioral or technological interventions to attenuate cognitive decline in individuals with dementia (such as Alzheimer’s disease, Lewy body dementia, vascular dementia), mild cognitive impairment (MCI), or disease- or age-related cognitive decline. Application budgets are not limited but need to reflect the actual needs of the proposed project.

High Throughput Screening (HTS) to Discover Chemical Probes:
Encourages investigators to form collaborations with an established academic, nonprofit, or commercial high throughput screening (HTS) facility that has the requisite expertise and experience to implement HTS-ready assays for the discovery and development of small molecule chemical probes. Application budgets are not limited but need to reflect the actual needs of the proposed project.

Preclinical Research on Model Organisms to Predict Treatment Outcomes for Disorders Associated with Intellectual and Developmental Disabilities:
Encourages applications from institutions/ organizations addressing preclinical research in model organisms of neurodevelopmental disorders. Budgets for direct costs of up to $499,999 per year may be requested.

Pregnancy in Women with Disabilities:
This FOA issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) encourages research project grants (R01) investigating the incidence, course, and outcomes of pregnancy among women with disabilities. Application budgets are not limited but need to reflect the actual needs of the proposed project.

Prevention Research in Mid-Life Adults (R01 Clinical Trial Optional):
This Funding Opportunity Announcement (FOA) seeks to stimulate research on mid-life adults (those 50 to 64 years of age) that can inform efforts to optimize health and well-being as individuals age and prevent illness and disability in later years.Application budgets are not limited but need to reflect the actual needs of the proposed project.

Promoting Research in Basic Neuroscience (R01 Clinical Trial Not Allowed):
he goal of this Funding Opportunity Announcement (FOA) is to stimulate research addressing fundamental questions in basic neuroscience. Application budgets are not limited but need to reflect the actual needs of the proposed project.

Details

Date:
February 5
Event Category:

Details

Date:
February 5
Event Category: